探讨氧驱雾化吸入普米克令舒治疗小儿哮喘急性发作的临床疗效

Clinical Efficacy of Oxygen Atomized Inhalation of Pulmicort in the Treatment of Acute Exacerbations of Asthma in Children

目的探讨氧驱雾化吸入普米克令舒治疗小儿哮喘急性发作的临床疗效。方法从该院于2015年4月—2017年2月就诊的儿科患者中,随机选取60例急性哮喘就诊的患儿作为研究对象,随机分为2组,每组30例患者。常规组给予常规治疗,研究组给予氧驱雾化吸入普米克令舒治疗。对比两组患者血气指标、肺功能、治疗疗效及不良反应的情况。结果研究组FVC、FEV1、FEV1/FVC改善情况均优于常规组;研究组治疗总有效率96.67%显著高于常规组76.67%;研究组不良反应总发生率6.67%显著低于常规组23.33%;差异有统计学意义(P<0.05)。结论小儿急性哮喘采用氧驱雾化吸入普米克令舒治疗可提高治疗疗效,改善患儿肺功能,且安全可靠。

Objective This paper tries to explore the clinical effect of oxygen atomized inhalation of Pulmicort in the treatment of acute exacerbations of asthma in children. Methods 60 cases of acute asthma patients from April 2015 to February2017 in this hospital were random selected and randomly divided into two groups, with 30 patients in each group. The routine group was given routine treatment; the study group was given oxygen atomized inhalation of pulmicort treatment. The blood gas index, lung function, therapeutic efficacy and adverse reactions were compared between the two groups. Results The improvement of FVC、FEV1、FEV1/FVC in the study group was better than the conventional group; the total effective rate was 96.67% in the study group, significantly higher than that of the conventional group of 76.67%; the total incidence of adverse effects was 6.67% in the study group, significantly lower than the conventional group of 23.33%; the differences were statistically significant（P〈0.05）. Conclusion The oxygen atomized inhalation of pulmicort treatment for acute asthma in children can improve curative effect and pulmonary function, which is safe and reliable.